Twin and family studies provide strong evidence for a substantial genetic contribution to OCD risk, with modern estimates of heritability around 40–50% (14–17), yet progress in identifying risk genes has been slow. Decades of linkage, common-variant candidate gene association studies, and more recent genome-wide association studies in OCD (18–20) have yielded few reproducible associations and therefore have provided limited insights into disease biology. Further efforts are clearly needed to identify specific OCD risk variants and to confirm vulnerability pathways by modern genome-wide and comprehensive variant discovery approaches.